(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

MIERS LABORATORIES

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

MIERS LABORATORIES

ST13

US500000097353658

Class

5

Filing

97353658

Registration

7290002

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

23

Latest update

01/23/2024

Trademark type

Word

Nice classes

5

Filing date

04/08/2022

Registration date

01/23/2024

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

01/23/2024

Last transaction

01/23/2024

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Supplemental Register

Filing basis

Intent to use

First use anywhere

1995-00-00

First use in commerce

1995-00-00

Drawing code

4

Owner type

99

Owner location

Wellington, NZ

Examiner

MOORE, CHRISTINA

Law office

M40

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

MIERS LABORATORIES LIMITED

Representatives

Jessie Reider Cristo BUCHALTER, APC

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Homeopathic pharmaceuticals for use in the treatment of jet-lagcircadian rhythm disordersfatigue; motion sickness treatment preparations; homeopathic supplements; homeopathic antiinflammatory ointment; pharmaceutical preparations for the treatment of insomnia; pharmaceutical preparations for the treatment of fatigue; pharmaceutical preparations for treating allergies; analgesic and muscle relaxant pharmaceutical preparations; pharmaceutical products for treating respiratory diseases; pharmaceutical anti-allergic preparations and substances; pharmaceutical products and preparations to prevent swelling in the legs; dietetic food and substances in the form of dropscapsulestablets or compressed tablets all of the foregoing in the nature of dietary supplements adapted for medical use; dietary supplements for humans; natural health food supplement; muscle relaxants; allergy medications; pharmaceutical preparations for the relief of sore throat pain

Publications

History of USPTO decisions and trademark events.

23 publications found

NRCS

NOTICE OF REGISTRATION CONFIRMATION EMAILED

01/23/2024

R.SR

REGISTERED-SUPPLEMENTAL REGISTER

01/23/2024

CNTA

APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER

09/15/2023

AAUA

NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED

09/12/2023

IUAA

USE AMENDMENT ACCEPTED

09/11/2023

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

08/17/2023

AUPC

AMENDMENT TO USE PROCESSING COMPLETE

08/17/2023

IUAF

USE AMENDMENT FILED

08/17/2023

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

08/16/2023

ERFR

TEAS REQUEST FOR RECONSIDERATION RECEIVED

08/16/2023

EAAU

TEAS AMENDMENT OF USE RECEIVED

08/16/2023

GNFN

NOTIFICATION OF FINAL REFUSAL EMAILED

07/11/2023

GNFR

FINAL REFUSAL E-MAILED

07/11/2023

CNFR

FINAL REFUSAL WRITTEN

07/11/2023

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

03/22/2023

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

03/22/2023

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

03/22/2023

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

02/07/2023

GNRT

NON-FINAL ACTION E-MAILED

02/07/2023

CNRT

NON-FINAL ACTION WRITTEN

02/07/2023

DOCK

ASSIGNED TO EXAMINER

01/26/2023

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

04/12/2022

NWAP

NEW APPLICATION ENTERED

04/12/2022

Continuous trademark protection

Get notified about every new filing that threatens MIERS LABORATORIES or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.